Healthcare provider profile · identity verified

Thomas J Lynch, M.D.

Internal Medicine · BALTIMORE, MD · NPI 1659312791

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	598	167
Rosuvastatin Calcium	Rosuvastatin Calcium	460	131
Amlodipine Besylate	Amlodipine Besylate	361	97
Losartan Potassium	Losartan Potassium	333	86
Metoprolol Succinate	Metoprolol Succinate	313	88
Simvastatin	Simvastatin	249	63
Lisinopril	Lisinopril	199	59
Levothyroxine Sodium	Levothyroxine Sodium	197	55
Omeprazole	Omeprazole	177	54
Pantoprazole Sodium	Pantoprazole Sodium	174	44
Eliquis	Apixaban	161	39
Furosemide	Furosemide	156	45
Hydrochlorothiazide	Hydrochlorothiazide	155	43
Tamsulosin Hcl	Tamsulosin Hcl	152	45
Ezetimibe	Ezetimibe	134	38
Metformin Hcl	Metformin Hcl	126	37
Telmisartan	Telmisartan	124	38
Gabapentin	Gabapentin	122	40
Carvedilol	Carvedilol	106	29
Allopurinol	Allopurinol	102	28
Bupropion Xl	Bupropion Hcl	97	26
Pravastatin Sodium	Pravastatin Sodium	97	29
Escitalopram Oxalate	Escitalopram Oxalate	95	28
Tramadol Hcl	Tramadol Hcl	95	17
Metoprolol Tartrate	Metoprolol Tartrate	94	26
Metformin Hcl Er	Metformin Hcl	91	26
Mounjaro	Tirzepatide	90	11
Zolpidem Tartrate	Zolpidem Tartrate	85	20
Finasteride	Finasteride	84	20
Potassium Chloride	Potassium Chloride	81	24
Synthroid	Levothyroxine Sodium	79	22
Chlorthalidone	Chlorthalidone	78	22
Sertraline Hcl	Sertraline Hcl	74	18
Jardiance	Empagliflozin	72	16
Alprazolam	Alprazolam	70	18
Lorazepam	Lorazepam	70	17
Pregabalin	Pregabalin	69	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	66	18
Duloxetine Hcl	Duloxetine Hcl	63	19
Famotidine	Famotidine	63	23
Valacyclovir	Valacyclovir Hcl	61	21
Albuterol Sulfate Hfa	Albuterol Sulfate	60	26
Montelukast Sodium	Montelukast Sodium	57	17
Atenolol	Atenolol	56	16
Xarelto	Rivaroxaban	56	11
Trazodone Hcl	Trazodone Hcl	54	16
Clopidogrel	Clopidogrel Bisulfate	53	20
Fluticasone Propionate	Fluticasone Propionate	53	15
Irbesartan	Irbesartan	48	13
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	46	suppressed
Hydralazine Hcl	Hydralazine Hcl	46	15
Memantine Hcl Er	Memantine Hcl	46	11
Azithromycin	Azithromycin	45	32
Celecoxib	Celecoxib	45	16
Clonazepam	Clonazepam	45	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	43	17
Olmesartan Medoxomil	Olmesartan Medoxomil	43	14
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	42	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	41	19
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	41	13
Mirtazapine	Mirtazapine	40	suppressed
Ibuprofen	Ibuprofen	39	18
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	39	11
Doxepin Hcl	Doxepin Hcl	38	16
Lansoprazole	Lansoprazole	38	11
Spironolactone	Spironolactone	35	11
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	34	11
Methylprednisolone	Methylprednisolone	33	29
Ozempic	Semaglutide	33	suppressed
Testosterone	Testosterone	33	suppressed
Glipizide Er	Glipizide	32	suppressed
Myrbetriq	Mirabegron	32	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	32	suppressed
Diazepam	Diazepam	30	11
Ipratropium Bromide	Ipratropium Bromide	29	13
Oxybutynin Chloride Er	Oxybutynin Chloride	29	suppressed
Prednisone	Prednisone	29	17
Verapamil Er	Verapamil Hcl	29	suppressed
Benazepril Hcl	Benazepril Hcl	28	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Meclizine Hcl	Meclizine Hcl	28	suppressed
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	27	suppressed
Entresto	Sacubitril/Valsartan	27	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	27	suppressed
Incruse Ellipta	Umeclidinium Bromide	27	suppressed
Meloxicam	Meloxicam	27	suppressed
Ammonium Lactate	Ammonium Lactate	26	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	26	suppressed
Propranolol Hcl	Propranolol Hcl	26	suppressed
Amoxicillin	Amoxicillin	25	21
Januvia	Sitagliptin Phosphate	25	suppressed
Ramipril	Ramipril	25	suppressed
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Trulicity	Dulaglutide	25	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	suppressed
Enalapril Maleate	Enalapril Maleate	24	suppressed
Memantine Hcl	Memantine Hcl	23	suppressed
Naltrexone Hcl	Naltrexone Hcl	23	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	23	suppressed
Alendronate Sodium	Alendronate Sodium	22	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	22	22
Esomeprazole Magnesium	Esomeprazole Magnesium	22	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	22	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	22	22
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	20	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Risedronate Sodium	Risedronate Sodium	20	suppressed
Synjardy Xr	Empagliflozin/Metformin Hcl	20	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	19	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	19	suppressed
Mupirocin	Mupirocin	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	17
Donepezil Hcl	Donepezil Hcl	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	suppressed
Estradiol	Estradiol	18	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	18	suppressed
Mometasone Furoate	Mometasone Furoate	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Acyclovir	Acyclovir	17	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	17	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	17	suppressed
Citalopram Hbr	Citalopram Hydrobromide	17	suppressed
Digoxin	Digoxin	17	suppressed
Fluconazole	Fluconazole	17	suppressed
Sildenafil Citrate	Sildenafil Citrate	17	suppressed
Solifenacin Succinate	Solifenacin Succinate	17	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	17	suppressed
Fluocinonide	Fluocinonide	16	11
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	15	suppressed
Latanoprost	Latanoprost	15	suppressed
Valsartan	Valsartan	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Emtricitabine-Tenofovir Disop	Emtricitabine/Tenofovir (Tdf)	14	suppressed
Glipizide	Glipizide	14	suppressed
Nystatin	Nystatin	14	suppressed
Verapamil Sr	Verapamil Hcl	14	suppressed
Xigduo Xr	Dapaglifloz Propaned/Metformin	14	suppressed
Zaleplon	Zaleplon	14	suppressed
Dutasteride	Dutasteride	13	suppressed
Klor-Con M20	Potassium Chloride	13	suppressed
Nebivolol Hcl	Nebivolol Hcl	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	13	suppressed
Topiramate	Topiramate	13	suppressed
Torsemide	Torsemide	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	11
Febuxostat	Febuxostat	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Hydroxyurea	Hydroxyurea	12	suppressed
Methotrexate	Methotrexate Sodium	12	suppressed
Niacin Er	Niacin	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Sulfasalazine	Sulfasalazine	12	suppressed
Temazepam	Temazepam	12	suppressed
Tresiba Flextouch U-200	Insulin Degludec	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error